期刊文献+

膀胱癌患者血清microRNA检测中内参基因的筛选及验证 被引量:5

Identification and validation of suitable reference genes for the investigation of serum microRNA in bladder cancer patients
原文传递
导出
摘要 目的筛选并验证适用于膀胱癌患者血清microRNA(miRNA)定量检测的内参基因。方法选取100例肌层浸润性膀胱癌患者、105例非肌层浸润性膀胱癌患者及139例健康对照者血清,通过Miseq测序筛选出表达较为稳定的miRNA,采用实时荧光定量PCR(qRT-PCR)法检测上述筛选出的miRNA及U6表达水平,利用geNorm及NormFinder软件对其稳定性进行分析,并在新的实验组中对软件所推荐内参基因及组合进行验证,选取miR-148b-3p作为靶分子,以进一步分析所选择内参基因的可靠性。结果采用qRT-PCR法对M iseq测序结果进行验证,筛选出hsa-miR-193a-5p、hsa-miR-16-5p、U6、hsa-miR-191-5p和hsa-let-7d-3p作为候选内参基因,经分析和验证后证实,hsa-miR-193a-5p作为内参基因最稳定,hsa-miR-193a-5p和hsa-miR-16-5p的组合为最佳内参组合。同时,miR-148b-3p在膀胱癌患者血清中明显上调并具有一定的诊断价值。结论在对膀胱癌血清miRNA检测时,hsa-miR-193a-5p为最稳定内参基因,hsa-miR-193a-5p和hsa-miR-16-5p为最佳组合,联合应用可使结果更为准确可靠。 Objective To identify the most stable reference genes for the quantification of serum miRNA in patients with bladder cancer. Methods A total of 100 muscle-invasive bladder cancer(M IBC) patients,105 non-muscle-invasive bladder cancer(NM IBC) patients,and 139 healthy controls were included in our study. MiSeq sequencing was performed,then the expressions of selected miRNAs by sequencing and U6 were examined by real time quantitative polymerase chain reaction(qRT-PCR),and the stability was analyzed with geNorm and NormFinder. The availability of the most stable reference genes was validated again in a newcohort. Furthermore,the miR-148b-3p was selected as a target gene to determine the effect of candidate normalizers on miRNA quantification. Results After confirmation by qRT-PCR,5 genes(hsa-miR-193a-5p,hsa-miR-16-5p,U6,hsa-miR-191-5p and hsa-let-7d-3p) were selected as candidate reference genes. The analysis and validation results showed that hsa-miR-193a-5p was the most stably expressed,and the combination of reference genes hsa-miR-193a-5p and hsa-miR-16-5p was suggested. Furthermore,the expression of miR-148b-3p in bladder cancer serum was significantly up-regulated and could be valuable in the diagnosis of bladdercancer. Conclusion Hsa-miR-193a-5p is the most stable and normalization of miRNA data using a combination of hsamiR-193a-5p and hsa-miR-16-5p as reference genes may produce reliable and accurate results for serum miRNAs study in bladder cancer.
出处 《山东大学学报(医学版)》 CAS 北大核心 2014年第5期86-91,共6页 Journal of Shandong University:Health Sciences
基金 国家自然科学基金(81271916)
关键词 膀胱癌 MICRORNA QRT-PCR 内参基因 Bladder cancer microRNA qRT-PCR Reference genes
  • 相关文献

参考文献3

二级参考文献40

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.

共引文献1004

同被引文献34

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部